Home - Research Teams - Neuronal coding and plasticity in epilepsy

Neuronal coding and plasticity in epilepsy

Neuronal coding and plasticity in epilepsy

Our team’s objective is to dissect the cellular and network mechanisms that drive epileptogenesis. We have established expertise in the pathophysiology of temporal lobe epilepsy (TLE), one of the most common focal epilepsies in adults. We discovered that ectopic kainate receptors (KARs) are expressed in the epileptic dentate gyrus, altering neuronal coding and excitability. In close collaboration with Christophe Mulle (IINS, Bordeaux), we showed that GluK2-containing KARs trigger recurrent seizures, identifying GluK2 as a promising target for drug-resistant epilepsy. This led to the development of a proof-of-concept gene therapy targeting hippocampal GluK2, culminating in the co-founding of Corlieve Therapeutics with academic and industry partners. Following uniQure’s acquisition, our AMT-260 candidate is now in Phase I/IIa clinical trials.

To see more +To see more -

The research group has a longstanding record of elucidating the pathophysiology of temporal lobe epilepsy (TLE), one of the most common forms of focal epilepsy in adults. In the epileptic hippocampus, dentate granule cells (DGCs) form new recurrent synapses. The team discovered that these synapses are not only aberrantly localized but also operate through a glutamatergic receptor subtype—kainate receptors (KARs)—that is absent under naïve conditions.

Over the past decade, our work has examined how ectopic KARs affect neuronal coding and drive seizure generation in DGCs in animal models of TLE. We first showed that ectopic KARs play a central role in TLE by profoundly altering neuronal coding properties and excitability. In close collaboration with Christophe Mulle, we demonstrated that ectopic KARs containing the GluK2 subunit are instrumental in precipitating recurrent seizures, thereby establishing GluK2 as a promising therapeutic target for drug‑resistant epilepsy.

Building on this foundation, we initiated a strategic maturation phase in partnership with INSERM Transfert, SATT Aquitaine, and Kurma Partners to develop a proof-of-concept gene therapy strategy targeting GluK2 in the hippocampus. This collaborative effort culminated in the establishment of Corlieve Therapeutics, co-founded with Christophe Mulle and bringing together academic partners (INSERM via INSERM Transfert, and CNRS via SATT Aquitaine) alongside industrial partners (Kurma Partners, Regenxbio, Eurazeo, Pureos Bioventures, and Bpifrance)

See Valérie Crépel, Prix Innovation 2022 and Corlieve Therapeutics rachetée par la biotech uniQure : un transfert réussi.

Following Corlieve’s acquisition by uniQure, the development of the AMT-260 drug candidate was accelerated and has now advanced to a Phase I/IIa clinical trial – see more

 

Selected references at the bottom of the page

Collaborators

INMED
Dr. J.C. Platel
Dr. A. Represa
Dr. R. Cossart

EXTERNAL
Dr. C. Mulle – Institut des Neurosciences, Bordeaux
Pr. F. Bartolomei – Hopital Timone, Marseille
Pr. D. Scavarda – Hopital Timone, Marseille

Alumni

L. Goirand-Lopez (PhD)
A. Vigier (PhD)
S. Ho (PhD)
C. Pléaux (PhD)
D. Ouedraogo (PhD)
J. Artinian (PhD)
J. Epsztein (PhD)
P. Congar (PhD)
G Bonetto (Postdoc)
A. Peret (Pos-doc)
L. Christie (Postdoc)
E. Sola (Postdoc)
M. Goldin (Postdoc)
)

Join our team !

Our team has open positions for master students, PhD students and post-docs. Please send your application by email to Valérie Crépel

Nos publications

A novel AAV9-dual microRNA-vector targeting in the hippocampus as a treatment for mesial temporal lobe epilepsy.

Baudouin SJ, Giles AR, Pearson N, Deforges S, He C, Boileau C, Partouche N, Borta A, Gautron J, Wartel M, Bočkaj I, Scavarda D, Bartolomei F, Penchet G, Aupy J, Sims J, Smith J, Mercer A, Danos O, Mulle C, Crépel V, Porter R

Molecular therapy. Methods & clinical development - Sep 2024

Kainate receptors modulate the microstructure of synchrony during dentate gyrus epileptiform activity.

Goirand-Lopez L, Moulinier M, Vigier A, Boileau C, Carleton A, Muldoon SF, Marissal T, Crépel V

Neurobiology of disease - Aug 2023

GluK2 is a target for gene therapy in drug-resistant Temporal Lobe Epilepsy.

Boileau C, Deforges S, Peret A, Scavarda D, Bartolomei F, Giles A, Partouche N, Gautron J, Viotti J, Janowitz H, Penchet G, Marchal C, Lagarde S, Trebuchon A, Villeneuve N, Rumi J, Marissal T, Khazipov R, Khalilov I, Martineau F, Maréchal M, Lepine A, Milh M, Figarella-Branger D, Dougy E, Tong S, Appay R, Baudouin S, Mercer A, Smith JB, Danos O, Porter R, Mulle C, Crépel V

Annals of neurology - Jun 2023

Regulation and dysregulation of neuronal circuits by KARs.

Mulle C, Crépel V

Neuropharmacology - Jul 2021

Impaired neuronal operation through aberrant intrinsic plasticity in epilepsy.

Artinian J, Peret A, Mircheva Y, Marti G, Crépel V

Annals of neurology - Jan 2015

Physiopathology of kainate receptors in epilepsy.

Crépel V, Mulle C

Current opinion in pharmacology - Dec 2014

Contribution of aberrant GluK2-containing kainate receptors to chronic seizures in temporal lobe epilepsy.

Peret A, Christie LA, Ouedraogo DW, Gorlewicz A, Epsztein J, Mulle C, Crépel V

Cell reports - Jul 2014

Synaptic kainate receptors in interplay with INaP shift the sparse firing of dentate granule cells to a sustained rhythmic mode in temporal lobe epilepsy.

Artinian J, Peret A, Marti G, Epsztein J, Crépel V

The Journal of neuroscience : the official journal of the Society for Neuroscience - Jul 2011

A selective interplay between aberrant EPSPKA and INaP reduces spike timing precision in dentate granule cells of epileptic rats.

Epsztein J, Sola E, Represa A, Ben-Ari Y, Crépel V

Cerebral cortex (New York, N.Y. : 1991) - Apr 2010

Recurrent mossy fibers establish aberrant kainate receptor-operated synapses on granule cells from epileptic rats.

Epsztein J, Represa A, Jorquera I, Ben-Ari Y, Crépel V

The Journal of neuroscience : the official journal of the Society for Neuroscience - Sep 2005

Abnormal UP/DOWN Membrane Potential Dynamics Coupled with the Neocortical Slow Oscillation in Dentate Granule Cells during the Latent Phase of Temporal Lobe Epilepsy.

Ouedraogo DW, Lenck-Santini PP, Marti G, Robbe D, Crépel V, Epsztein J

eNeuro - Jun May 2016

Activity-dependent gating of calcium spikes by A-type K+ channels controls climbing fiber signaling in Purkinje cell dendrites.

Otsu Y, Marcaggi P, Feltz A, Isope P, Kollo M, Nusser Z, Mathieu B, Kano M, Tsujita M, Sakimura K, Dieudonné S

Neuron - Oct 2014

The information content of physiological and epileptic brain activity.

Trevelyan AJ, Bruns W, Mann EO, Crepel V, Scanziani M

The Journal of physiology - Feb 2013

An epilepsy-related ARX polyalanine expansion modifies glutamatergic neurons excitability and morphology without affecting GABAergic neurons development.

Beguin S, Crépel V, Aniksztejn L, Becq H, Pelosi B, Pallesi-Pocachard E, Bouamrane L, Pasqualetti M, Kitamura K, Cardoso C, Represa A

Cerebral cortex (New York, N.Y. : 1991) - Jun 2013

Inhibitory actions of the gamma-aminobutyric acid in pediatric Sturge-Weber syndrome.

Tyzio R, Khalilov I, Represa A, Crepel V, Zilberter Y, Rheims S, Aniksztejn L, Cossart R, Nardou R, Mukhtarov M, Minlebaev M, Epsztein J, Milh M, Becq H, Jorquera I, Bulteau C, Fohlen M, Oliver V, Dulac O, Dorfmüller G, Delalande O, Ben-Ari Y, Khazipov R

Annals of neurology - Aug 2009

Abnormal network activity in a targeted genetic model of human double cortex.

Ackman JB, Aniksztejn L, Crépel V, Becq H, Pellegrino C, Cardoso C, Ben-Ari Y, Represa A

The Journal of neuroscience : the official journal of the Society for Neuroscience - Jan 2009

Seizures beget seizures in temporal lobe epilepsies: the boomerang effects of newly formed aberrant kainatergic synapses.

Ben-Ari Y, Crepel V, Represa A

Epilepsy currents / American Epilepsy Society -

Late-onset epileptogenesis and seizure genesis: lessons from models of cerebral ischemia.

Epsztein J, Ben-Ari Y, Represa A, Crépel V

The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry - Feb 2008
voir toutes les publications +

ALUMNI

  • Lucas GOIRAND-LOPEZ - 2017-2024 - doctorant & post-doctorant